Sign in

CIK 0001108205

  • Non-accelerated filer
  • Smaller reporting company
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043505116
Phone
+1 617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2011-01-07 Keegan Mitchell Vice-President Grant or award · Qualified stock option (right to buy) +30,254 30,254
2011-01-07 Keegan Mitchell Vice-President Grant or award · Non-qualified stock option (right to buy) +29,746 29,746
2010-02-02 Keegan Mitchell Vice-President Grant or award · Qualified stock option (right to buy) +25,283 25,283
2010-02-02 Keegan Mitchell Vice-President Grant or award · Non-qualified stock option (right to buy) +34,717 34,717
2009-09-02 Keegan Mitchell Vice-President Grant or award · Qualified stock option (right to buy) +81,139 81,139
2009-09-02 Keegan Mitchell Vice-President Grant or award · Non-qualified stock option (right to buy) +18,861 18,861

Page 1 of 1 · 6 trades